New Approaches to Targeted Therapy in Melanoma
Cancers · 17.06.2023 · 15 (12) · 3224
DOI: 10.3390/cancers15123224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.06.2023. Verfasst von Manuel Felipe Fernandez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611…. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
It was just slightly more than a decade ago when metastatic melanoma carried a dismal prognosis with few, if any, effective therapies. Since then, the evolution of cancer immunotherapy has led to new and effective treatment approaches for melanoma. However, despite these advances, a sizable portion of patients with advanced melanoma have de novo or acquired resistance to immune checkpoint inhibitors. At the same time, therapies (BRAF plus MEK inhibitors) targeting the BRAFV600 mutations found in 40–50% of cutaneous melanomas have also been critical for optimizing management and improving patient outcomes. Even though immunotherapy has been established as the initial therapy in most patients with cutaneous melanoma, subsequent effective therapy is limited to BRAFV600 melanoma. For all other melanoma patients, driver mutations have not been effectively targeted. Numerous efforts are underway to target melanomas with NRAS mutations, NF-1 LOF mutations, and other genetic alterations leading to activation of the MAP kinase pathway. In this era of personalized medicine, we will review the current genetic landscape, molecular classifications, emerging drug targets, and the potential for combination therapies for non-BRAFV600 melanoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Zitieren
APA
Fernandez, M. F., Choi, J., & Sosman, J. (2023). New Approaches to Targeted Therapy in Melanoma. Cancers, 15(12), 3224. https://doi.org/10.3390/cancers15123224
Vancouver
Fernandez MF, Choi J, Sosman J. New Approaches to Targeted Therapy in Melanoma. Cancers. 2023;15(12):3224. doi:10.3390/cancers15123224
BibTeX
@article{Fernandez2023,
author = {Fernandez, Manuel Felipe and Choi, Jacob and Sosman, Jeffrey},
title = {New Approaches to Targeted Therapy in Melanoma},
journal = {Cancers},
year = {2023},
volume = {15},
number = {12},
pages = {3224},
doi = {10.3390/cancers15123224}
}
EUVIMED